| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.22 | 0.09 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.055 | 0.09 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.09 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | 0.3 | 0.09 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.1 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.1 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.1 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.097 | 0.1 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.09 | 0.1 |